Name

CAPIRI

Alternate names

XELIRI

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CAPIRI

Name

Alternate Names

Camptosar
Camptosar Oral
Camptothecin-11
CPT 11
CPT-11
CPT11
U-101440E

Abbreviations

None

Category

Chemotherapy

Subcategory

Topoisomerase inhibitor

NSC Number

616348

Primary Site

Colorectal
head & neck
Non-small cell lung cancer (NSCLC)
pancreatic cancer
Small cell lung cancer (SCLC)

Histology

None

Remarks

Phase I (head & neck) Phase III SCLC pancreatic Topoisomerase I inhibitor. FDA approved use on colorectal cancer. Pharmacia.

Coding

This drug should be coded

Name

Alternate Names

Ro 091978
Ro-09-1978
Ro-091978
Xeloda

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

712807

Primary Site

Breast cancer
colorectal cancer

Histology

None

Remarks

FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.

Coding

This drug should be coded
Glossary